Cytosorbents Ownership 2024 | Who Owns Cytosorbents Now?
Institutional Ownership
19.17%
Insider Ownership
3.84%
Retail Ownership
76.99%
Institutional Holders
32.00
Cytosorbents Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVENIR CORP | 5.47% | 0.20% | 2,970,262 | -202,434 | -6.38% | 2,088,094 | Jun 30, 2024 |
| SKYLANDS CAPITAL, LLC | 5.24% | 0.28% | 2,840,778 | -34,774 | -1.21% | 1,997,067 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 4.91% | 0.07% | 2,663,811 | -381,022 | -12.51% | 1,872,659 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.59% | - | 1,949,551 | - | - | 1,370,534 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 2.83% | 0.00% | 1,536,514 | -376,052 | -19.66% | 1,080,174 | Jun 30, 2024 |
| SARGENT INVESTMENT GROUP, LLC | 2.64% | 0.21% | 1,433,500 | 67,181 | 4.92% | 1,007,751 | Jun 30, 2024 |
| CM MANAGEMENT, LLC | 1.57% | 0.55% | 850,000 | 25,000 | 3.03% | 597,550 | Jun 30, 2024 |
| BLACKROCK INC. | 1.21% | - | 655,805 | -66,630 | -9.22% | 461,031 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.80% | - | 434,643 | -3,654 | -0.83% | 305,624 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.32% | 0.00% | 172,649 | - | - | 174,375 | Jun 30, 2024 |
| STATE STREET CORP | 0.26% | - | 140,293 | - | - | 98,626,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.21% | - | 114,223 | -2,162 | -1.86% | 80,300 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.21% | 0.00% | 112,420 | -1,390 | -1.22% | 78,770 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.14% | 0.00% | 75,820 | -3,800 | -4.77% | 53,301 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 74,861 | -152 | -0.20% | 52,627,000 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.11% | 0.00% | 60,591 | - | - | 42,595 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.09% | - | 50,000 | - | - | 35,150 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.08% | - | 45,000 | - | - | 31,635 | Jun 30, 2024 |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 0.06% | 0.01% | 34,557 | - | - | 24,294 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.06% | - | 34,451 | -2,447 | -6.63% | 24,219 | Jun 30, 2024 |
Cytosorbents's largest institutional shareholder is AVENIR CORP, holding 5.47% of the company's total share outstanding, currently valued at $2.09M. The top 10 institutional shareholders own together 28.58% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CM MANAGEMENT, LLC | 1.57% | 0.55% | 850,000 | 25,000 | 3.03% | 597,550 | Jun 30, 2024 |
| SKYLANDS CAPITAL, LLC | 5.24% | 0.28% | 2,840,778 | -34,774 | -1.21% | 1,997,067 | Jun 30, 2024 |
| SARGENT INVESTMENT GROUP, LLC | 2.64% | 0.21% | 1,433,500 | 67,181 | 4.92% | 1,007,751 | Jun 30, 2024 |
| AVENIR CORP | 5.47% | 0.20% | 2,970,262 | -202,434 | -6.38% | 2,088,094 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 4.91% | 0.07% | 2,663,811 | -381,022 | -12.51% | 1,872,659 | Jun 30, 2024 |
| SEELAUS ASSET MANAGEMENT LLC | 0.03% | 0.01% | 18,800 | -150 | -0.79% | 13,216 | Jun 30, 2024 |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 0.06% | 0.01% | 34,557 | - | - | 24,294 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.02% | 0.00% | 8,200 | 8,200 | 100.00% | 5,765 | Jun 30, 2024 |
| TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC | 0.04% | 0.00% | 23,166 | - | - | 16,286 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 2.83% | 0.00% | 1,536,514 | -376,052 | -19.66% | 1,080,174 | Jun 30, 2024 |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 0.04% | 0.00% | 19,084 | -11,583 | -37.77% | 22,615 | Jun 30, 2024 |
| COUNTRY CLUB BANK /GFN | 0.03% | 0.00% | 15,225 | - | - | 11,761 | Jun 30, 2024 |
| HEXAGON CAPITAL PARTNERS LLC | 0.01% | 0.00% | 3,333 | - | - | 2,344 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.32% | 0.00% | 172,649 | - | - | 174,375 | Jun 30, 2024 |
| SOA WEALTH ADVISORS, LLC. | 0.00% | 0.00% | 2,222 | - | - | 1,562 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 21,699 | 13,675 | 170.43% | 15,254 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.21% | 0.00% | 112,420 | -1,390 | -1.22% | 78,770 | Jun 30, 2024 |
| RESOURCES INVESTMENT ADVISORS, LLC. | 0.03% | 0.00% | 15,000 | - | - | 10,545 | Jun 30, 2024 |
| JOHNSON INVESTMENT COUNSEL INC | 0.03% | 0.00% | 17,434 | -1,953 | -10.07% | 12,256 | Jun 30, 2024 |
| BRADLEY FOSTER & SARGENT INC/CT | 0.02% | 0.00% | 10,000 | - | - | 7,030 | Jun 30, 2024 |
The largest Cytosorbents shareholder by % of total assets is CM MANAGEMENT, LLC. The company owns 850.00K shares of Cytosorbents (CTSO), representing 0.55% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SARGENT INVESTMENT GROUP, LLC | 2.64% | 0.21% | 1,433,500 | 67,181 | 4.92% | 1,007,751 | Jun 30, 2024 |
| CM MANAGEMENT, LLC | 1.57% | 0.55% | 850,000 | 25,000 | 3.03% | 597,550 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 21,699 | 13,675 | 170.43% | 15,254 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.02% | 0.00% | 8,200 | 8,200 | 100.00% | 5,765 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.03% | - | 18,560 | 4,089 | 28.26% | 12,940,000 | Jun 30, 2024 |
| COMERICA BANK | 0.01% | - | 3,447 | 2,610 | 311.83% | 2,423 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 1,857 | 1,800 | 3157.89% | 1,305 | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 285 | 285 | 100.00% | 200 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 1 | - | - | 1 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | 3 | - | - | 2 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 31 | - | - | 22 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 372 | - | - | 262 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 37 | - | - | 39 | Jun 30, 2024 |
| STATE STREET CORP | 0.26% | - | 140,293 | - | - | 98,626,000 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.09% | - | 50,000 | - | - | 35,150 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.59% | - | 1,949,551 | - | - | 1,370,534 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.08% | - | 45,000 | - | - | 31,635 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.11% | 0.00% | 60,591 | - | - | 42,595 | Jun 30, 2024 |
| YOUR ADVOCATES LTD., LLP | 0.00% | 0.00% | 250 | - | - | 175 | Jun 30, 2024 |
| BRADLEY FOSTER & SARGENT INC/CT | 0.02% | 0.00% | 10,000 | - | - | 7,030 | Jun 30, 2024 |
As of Jun 30 2024, Cytosorbents's largest institutional buyer is SARGENT INVESTMENT GROUP, LLC. The company purchased 67.18K stocks of CTSO, valued at $1.01M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 4.91% | 0.07% | 2,663,811 | -381,022 | -12.51% | 1,872,659 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 2.83% | 0.00% | 1,536,514 | -376,052 | -19.66% | 1,080,174 | Jun 30, 2024 |
| AVENIR CORP | 5.47% | 0.20% | 2,970,262 | -202,434 | -6.38% | 2,088,094 | Jun 30, 2024 |
| BLACKROCK INC. | 1.21% | - | 655,805 | -66,630 | -9.22% | 461,031 | Jun 30, 2024 |
| SKYLANDS CAPITAL, LLC | 5.24% | 0.28% | 2,840,778 | -34,774 | -1.21% | 1,997,067 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.04% | - | 19,941 | -15,902 | -44.37% | 14,019 | Jun 30, 2024 |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 0.04% | 0.00% | 19,084 | -11,583 | -37.77% | 22,615 | Jun 30, 2024 |
| REGAL INVESTMENT ADVISORS LLC | - | - | - | -11,509 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.14% | 0.00% | 75,820 | -3,800 | -4.77% | 53,301 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.80% | - | 434,643 | -3,654 | -0.83% | 305,624 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -3,640 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.06% | - | 34,451 | -2,447 | -6.63% | 24,219 | Jun 30, 2024 |
| MORGAN STANLEY | 0.21% | - | 114,223 | -2,162 | -1.86% | 80,300 | Jun 30, 2024 |
| JOHNSON INVESTMENT COUNSEL INC | 0.03% | 0.00% | 17,434 | -1,953 | -10.07% | 12,256 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.21% | 0.00% | 112,420 | -1,390 | -1.22% | 78,770 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -1,090 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 453 | -343 | -43.09% | 319 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 74,861 | -152 | -0.20% | 52,627,000 | Jun 30, 2024 |
| SEELAUS ASSET MANAGEMENT LLC | 0.03% | 0.01% | 18,800 | -150 | -0.79% | 13,216 | Jun 30, 2024 |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 0.06% | 0.01% | 34,557 | - | - | 24,294 | Jun 30, 2024 |
As of Jun 30 2024, Cytosorbents's biggest institutional seller is GRANAHAN INVESTMENT MANAGEMENT, LLC. The company sold -0.38M shares of CTSO, valued at $1.87M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.02% | 0.00% | 8,200 | 8,200 | 100.00% | 5,765 | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 285 | 285 | 100.00% | 200 | Jun 30, 2024 |
Cytosorbents's largest new institutional shareholder by number of shares is REDWOOD WEALTH MANAGEMENT GROUP, LLC, purchased 8.20K shares, valued at $5.76K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REGAL INVESTMENT ADVISORS LLC | - | - | - | -11,509 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -3,640 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -1,090 | -100.00% | - | Jun 30, 2024 |
Cytosorbents's largest sold out institutional shareholder by shares sold is REGAL INVESTMENT ADVISORS LLC, sold -11.51K shares, valued at -, as of undefined.
Cytosorbents Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 3.89% | 13,875 | - | - | Feb 29, 2024 |
| Jacob Funds Inc. | 0.86% | 197,940 | - | - | Feb 29, 2024 |
| Cushing Mutual Funds Trust | 0.74% | 21,447 | - | - | Aug 31, 2023 |
| WP Trust | 0.14% | 20,000 | - | - | Feb 29, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.09% | 901,950 | 366,404 | 68.42% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 35,641 | - | - | Mar 31, 2024 |
| ROYCE FUND | 0.05% | 349,000 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.05% | 45,502 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,431 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 64,033 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 10,572 | -8,811 | -45.46% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,039 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,870,449 | -568,233 | -23.30% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 457,469 | 272,574 | 147.42% | Jan 31, 2024 |
| Harbor ETF Trust | 0.00% | 7,979 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 346,230 | 16,215 | 4.91% | Feb 29, 2024 |
| Virtus Strategy Trust | 0.00% | 32,611 | - | - | Mar 28, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,468 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 29,596 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 4,203 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 339 | - | - | Apr 30, 2021 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 16,730 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 23,517 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 10,282 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 15,994 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,173 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,304 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 11,563 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 1,133 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 913 | - | - | Mar 28, 2024 |
| HC CAPITAL TRUST | 0.00% | 7,035 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 20,132 | - | - | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 18,107 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 466 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 22,145 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,634 | - | - | Mar 31, 2024 |
| Virtus Investment Trust | 0.00% | 4,395 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,660 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 2,951 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 395 | - | - | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 5,110 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 306,404 | - | - | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 23,603 | 16,817 | 247.82% | Dec 31, 2023 |
| ProFunds | 0.00% | 882 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 141,061 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,259 | - | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 3,609 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 217 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 15,284 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 19,040 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 5,579 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,500 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 245 | - | - | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,081 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 1,100 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 107,469 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 7,469 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 39 | - | - | Dec 31, 2023 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 8,707 | 8,707 | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 26,160 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 10,417 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 5,941 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 19,029 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 15,424 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 305 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 34,700 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 1,517 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,547 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 22,219 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 7,170 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 87,960 | -1,970 | -2.19% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 14,860 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,625 | - | - | Dec 31, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 300 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 5,523 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 5,384 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 6,300 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 5,026 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 50 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 847 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 4,966 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 5,500 | - | - | Feb 29, 2024 |
Cytosorbents's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 13.88K shares, compromising 3.89% of its total assets.
Cytosorbents Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 32 | -31.91% |
| 31 Mar, 24 | 47 | -7.84% |
| 31 Dec, 23 | 51 | -5.56% |
| 30 Sep, 23 | 54 | -8.47% |
| 30 Jun, 23 | 59 | -4.84% |
| 31 Mar, 23 | 62 | 16.98% |
| 31 Dec, 22 | 53 | -7.02% |
| 30 Sep, 22 | 57 | -22.97% |
| 30 Jun, 22 | 74 | -13.95% |
| 31 Mar, 22 | 86 | -6.52% |
| 31 Dec, 21 | 92 | -6.12% |
| 30 Sep, 21 | 98 | -3.92% |
| 30 Jun, 21 | 102 | 4.08% |
| 31 Mar, 21 | 98 | 2.08% |
| 31 Dec, 20 | 96 | -2.04% |
| 30 Sep, 20 | 98 | 3.16% |
| 30 Jun, 20 | 95 | 13.10% |
| 31 Mar, 20 | 84 | 18.31% |
| 31 Dec, 19 | 71 | 2.90% |
| 30 Sep, 19 | 69 | -1.43% |
| 30 Jun, 19 | 70 | -10.26% |
| 31 Mar, 19 | 78 | -10.34% |
| 31 Dec, 18 | 87 | 6.10% |
| 30 Sep, 18 | 82 | 2.50% |
| 30 Jun, 18 | 80 | 45.45% |
| 31 Mar, 18 | 55 | 12.24% |
| 31 Dec, 17 | 49 | 36.11% |
| 30 Sep, 17 | 36 | 2.86% |
| 30 Jun, 17 | 35 | -7.89% |
| 31 Mar, 17 | 38 | -7.32% |
| 31 Dec, 16 | 41 | 7.89% |
| 30 Sep, 16 | 38 | - |
| 30 Jun, 16 | 38 | 2.70% |
| 31 Mar, 16 | 37 | -15.91% |
| 31 Dec, 15 | 44 | 18.92% |
| 30 Sep, 15 | 37 | 8.82% |
| 30 Jun, 15 | 34 | 17.24% |
| 31 Mar, 15 | 29 | 222.22% |
| 31 Dec, 14 | 9 | - |
As of 30 Jun 24, 32 institutions are holding Cytosorbents's shares, representing a decrease of -31.91% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 10,402,816 | -40.66% |
| 31 Mar, 24 | 17,531,124 | -2.28% |
| 31 Dec, 23 | 17,940,758 | 18.13% |
| 30 Sep, 23 | 15,187,943 | 0.02% |
| 30 Jun, 23 | 15,184,349 | 0.12% |
| 31 Mar, 23 | 15,166,201 | 3.50% |
| 31 Dec, 22 | 14,653,316 | -1.28% |
| 30 Sep, 22 | 14,844,012 | -4.09% |
| 30 Jun, 22 | 15,477,325 | -14.15% |
| 31 Mar, 22 | 18,029,050 | 1.18% |
| 31 Dec, 21 | 17,818,029 | -3.12% |
| 30 Sep, 21 | 18,391,880 | 5.06% |
| 30 Jun, 21 | 17,506,400 | 0.25% |
| 31 Mar, 21 | 17,462,176 | -0.56% |
| 31 Dec, 20 | 17,560,225 | 2.22% |
| 30 Sep, 20 | 17,178,590 | 52.56% |
| 30 Jun, 20 | 11,259,887 | 13.36% |
| 31 Mar, 20 | 9,932,795 | 11.28% |
| 31 Dec, 19 | 8,925,979 | 5.84% |
| 30 Sep, 19 | 8,433,618 | -0.76% |
| 30 Jun, 19 | 8,498,014 | -0.08% |
| 31 Mar, 19 | 8,505,008 | -1.54% |
| 31 Dec, 18 | 8,638,276 | 5.62% |
| 30 Sep, 18 | 8,178,397 | 4.50% |
| 30 Jun, 18 | 7,826,543 | 99.37% |
| 31 Mar, 18 | 3,925,584 | 22.42% |
| 31 Dec, 17 | 3,206,663 | 29.19% |
| 30 Sep, 17 | 2,482,137 | 28.06% |
| 30 Jun, 17 | 1,938,266 | -21.01% |
| 31 Mar, 17 | 2,453,743 | 53.86% |
| 31 Dec, 16 | 1,594,828 | 1.62% |
| 30 Sep, 16 | 1,569,433 | -11.50% |
| 30 Jun, 16 | 1,773,298 | 25.58% |
| 31 Mar, 16 | 1,412,125 | 2.64% |
| 31 Dec, 15 | 1,375,745 | 1.86% |
| 30 Sep, 15 | 1,350,665 | 8.73% |
| 30 Jun, 15 | 1,242,189 | 30.15% |
| 31 Mar, 15 | 954,417 | 142.09% |
| 31 Dec, 14 | 394,240 | - |
Cytosorbents (CTSO) has 10.40M shares outstanding as of 30 Jun 24, down -40.66% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 19.17% | 1.24% |
| 31 Mar, 24 | 39.26% | 2.40% |
| 31 Dec, 23 | 40.43% | 3.40% |
| 30 Sep, 23 | 34.51% | 2.85% |
| 30 Jun, 23 | 34.77% | 2.88% |
| 31 Mar, 23 | 34.72% | 2.44% |
| 31 Dec, 22 | 37.75% | 3.26% |
| 30 Sep, 22 | 34.04% | 2.70% |
| 30 Jun, 22 | 35.53% | 2.07% |
| 31 Mar, 22 | 41.46% | 2.47% |
| 31 Dec, 21 | 40.98% | 2.28% |
| 30 Sep, 21 | 42.38% | 2.59% |
| 30 Jun, 21 | 40.41% | 2.48% |
| 31 Mar, 21 | 40.38% | 2.27% |
| 31 Dec, 20 | 42.22% | 2.47% |
| 30 Sep, 20 | 41.30% | 4.34% |
| 30 Jun, 20 | 30.86% | 3.61% |
| 31 Mar, 20 | 29.23% | 4.24% |
| 31 Dec, 19 | 26.27% | 3.87% |
| 30 Sep, 19 | 26.06% | 3.76% |
| 30 Jun, 19 | 26.34% | 3.71% |
| 31 Mar, 19 | 26.64% | 3.64% |
| 31 Dec, 18 | 27.05% | 3.96% |
| 30 Sep, 18 | 26.12% | 3.92% |
| 30 Jun, 18 | 25.83% | 14.44% |
| 31 Mar, 18 | 13.37% | 11.21% |
| 31 Dec, 17 | 10.93% | 14.11% |
| 30 Sep, 17 | 8.80% | 18.30% |
| 30 Jun, 17 | 6.93% | 7.49% |
| 31 Mar, 17 | 9.62% | 24.60% |
| 31 Dec, 16 | 6.25% | 16.44% |
| 30 Sep, 16 | 6.17% | 12.67% |
| 30 Jun, 16 | 6.98% | 20.83% |
| 31 Mar, 16 | 5.79% | 18.21% |
| 31 Dec, 15 | 5.64% | 19.37% |
| 30 Sep, 15 | 5.39% | 21.45% |
| 30 Jun, 15 | 5.02% | 32.77% |
| 31 Mar, 15 | 3.91% | 52.07% |
| 31 Dec, 14 | 2.74% | - |
As of 30 Jun 24, Cytosorbents is held by 19.17% institutional shareholders, representing a 1.24% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | -57.14% |
| 31 Mar, 24 | 14 | -30.00% |
| 31 Dec, 23 | 20 | 11.11% |
| 30 Sep, 23 | 18 | -33.33% |
| 30 Jun, 23 | 27 | 22.73% |
| 31 Mar, 23 | 22 | - |
| 31 Dec, 22 | 22 | 37.50% |
| 30 Sep, 22 | 16 | -52.94% |
| 30 Jun, 22 | 34 | -12.82% |
| 31 Mar, 22 | 39 | -13.33% |
| 31 Dec, 21 | 45 | 12.50% |
| 30 Sep, 21 | 40 | 2.56% |
| 30 Jun, 21 | 39 | -15.22% |
| 31 Mar, 21 | 46 | -4.17% |
| 31 Dec, 20 | 48 | -7.69% |
| 30 Sep, 20 | 52 | -18.75% |
| 30 Jun, 20 | 64 | 33.33% |
| 31 Mar, 20 | 48 | 37.14% |
| 31 Dec, 19 | 35 | 9.38% |
| 30 Sep, 19 | 32 | 3.23% |
| 30 Jun, 19 | 31 | -8.82% |
| 31 Mar, 19 | 34 | -17.07% |
| 31 Dec, 18 | 41 | 2.50% |
| 30 Sep, 18 | 40 | -31.03% |
| 30 Jun, 18 | 58 | 70.59% |
| 31 Mar, 18 | 34 | - |
| 31 Dec, 17 | 34 | 126.67% |
| 30 Sep, 17 | 15 | 36.36% |
| 30 Jun, 17 | 11 | -47.62% |
| 31 Mar, 17 | 21 | 16.67% |
| 31 Dec, 16 | 18 | -5.26% |
| 30 Sep, 16 | 19 | 11.76% |
| 30 Jun, 16 | 17 | 30.77% |
| 31 Mar, 16 | 13 | -48.00% |
| 31 Dec, 15 | 25 | 78.57% |
| 30 Sep, 15 | 14 | -26.32% |
| 30 Jun, 15 | 19 | -24.00% |
| 31 Mar, 15 | 25 | 177.78% |
| 31 Dec, 14 | 9 | - |
6 institutional shareholders have increased their position in CTSO stock as of 30 Jun 24 compared to 14 in the previous quarter (a -57.14% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -33.33% |
| 31 Mar, 24 | 15 | 7.14% |
| 31 Dec, 23 | 14 | -12.50% |
| 30 Sep, 23 | 16 | 45.45% |
| 30 Jun, 23 | 11 | -38.89% |
| 31 Mar, 23 | 18 | 5.88% |
| 31 Dec, 22 | 17 | - |
| 30 Sep, 22 | 17 | -26.09% |
| 30 Jun, 22 | 23 | -14.81% |
| 31 Mar, 22 | 27 | 3.85% |
| 31 Dec, 21 | 26 | -3.70% |
| 30 Sep, 21 | 27 | -30.77% |
| 30 Jun, 21 | 39 | 39.29% |
| 31 Mar, 21 | 28 | 47.37% |
| 31 Dec, 20 | 19 | -13.64% |
| 30 Sep, 20 | 22 | 100.00% |
| 30 Jun, 20 | 11 | -38.89% |
| 31 Mar, 20 | 18 | -10.00% |
| 31 Dec, 19 | 20 | 5.26% |
| 30 Sep, 19 | 19 | -9.52% |
| 30 Jun, 19 | 21 | -4.55% |
| 31 Mar, 19 | 22 | - |
| 31 Dec, 18 | 22 | -4.35% |
| 30 Sep, 18 | 23 | 283.33% |
| 30 Jun, 18 | 6 | -25.00% |
| 31 Mar, 18 | 8 | 33.33% |
| 31 Dec, 17 | 6 | - |
| 30 Sep, 17 | 6 | -57.14% |
| 30 Jun, 17 | 14 | 55.56% |
| 31 Mar, 17 | 9 | - |
| 31 Dec, 16 | 9 | 12.50% |
| 30 Sep, 16 | 8 | 33.33% |
| 30 Jun, 16 | 6 | -14.29% |
| 31 Mar, 16 | 7 | 16.67% |
| 31 Dec, 15 | 6 | -33.33% |
| 30 Sep, 15 | 9 | 125.00% |
| 30 Jun, 15 | 4 | - |
| 31 Mar, 15 | - | - |
| 31 Dec, 14 | - | - |
10 institutional shareholders have reduced their position in CTSO stock as of 30 Jun 24 compared to 15 in the previous quarter (a -33.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 32 | -31.91% | 10,402,816 | -40.66% | 19.17% | 1.24% | 6 | -57.14% | 10 | -33.33% |
| 31 Mar, 24 | 47 | -7.84% | 17,531,124 | -2.28% | 39.26% | 2.40% | 14 | -30.00% | 15 | 7.14% |
| 31 Dec, 23 | 51 | -5.56% | 17,940,758 | 18.13% | 40.43% | 3.40% | 20 | 11.11% | 14 | -12.50% |
| 30 Sep, 23 | 54 | -8.47% | 15,187,943 | 0.02% | 34.51% | 2.85% | 18 | -33.33% | 16 | 45.45% |
| 30 Jun, 23 | 59 | -4.84% | 15,184,349 | 0.12% | 34.77% | 2.88% | 27 | 22.73% | 11 | -38.89% |
| 31 Mar, 23 | 62 | 16.98% | 15,166,201 | 3.50% | 34.72% | 2.44% | 22 | - | 18 | 5.88% |
| 31 Dec, 22 | 53 | -7.02% | 14,653,316 | -1.28% | 37.75% | 3.26% | 22 | 37.50% | 17 | - |
| 30 Sep, 22 | 57 | -22.97% | 14,844,012 | -4.09% | 34.04% | 2.70% | 16 | -52.94% | 17 | -26.09% |
| 30 Jun, 22 | 74 | -13.95% | 15,477,325 | -14.15% | 35.53% | 2.07% | 34 | -12.82% | 23 | -14.81% |
| 31 Mar, 22 | 86 | -6.52% | 18,029,050 | 1.18% | 41.46% | 2.47% | 39 | -13.33% | 27 | 3.85% |
| 31 Dec, 21 | 92 | -6.12% | 17,818,029 | -3.12% | 40.98% | 2.28% | 45 | 12.50% | 26 | -3.70% |
| 30 Sep, 21 | 98 | -3.92% | 18,391,880 | 5.06% | 42.38% | 2.59% | 40 | 2.56% | 27 | -30.77% |
| 30 Jun, 21 | 102 | 4.08% | 17,506,400 | 0.25% | 40.41% | 2.48% | 39 | -15.22% | 39 | 39.29% |
| 31 Mar, 21 | 98 | 2.08% | 17,462,176 | -0.56% | 40.38% | 2.27% | 46 | -4.17% | 28 | 47.37% |
| 31 Dec, 20 | 96 | -2.04% | 17,560,225 | 2.22% | 42.22% | 2.47% | 48 | -7.69% | 19 | -13.64% |
| 30 Sep, 20 | 98 | 3.16% | 17,178,590 | 52.56% | 41.30% | 4.34% | 52 | -18.75% | 22 | 100.00% |
| 30 Jun, 20 | 95 | 13.10% | 11,259,887 | 13.36% | 30.86% | 3.61% | 64 | 33.33% | 11 | -38.89% |
| 31 Mar, 20 | 84 | 18.31% | 9,932,795 | 11.28% | 29.23% | 4.24% | 48 | 37.14% | 18 | -10.00% |
| 31 Dec, 19 | 71 | 2.90% | 8,925,979 | 5.84% | 26.27% | 3.87% | 35 | 9.38% | 20 | 5.26% |
| 30 Sep, 19 | 69 | -1.43% | 8,433,618 | -0.76% | 26.06% | 3.76% | 32 | 3.23% | 19 | -9.52% |
| 30 Jun, 19 | 70 | -10.26% | 8,498,014 | -0.08% | 26.34% | 3.71% | 31 | -8.82% | 21 | -4.55% |
| 31 Mar, 19 | 78 | -10.34% | 8,505,008 | -1.54% | 26.64% | 3.64% | 34 | -17.07% | 22 | - |
| 31 Dec, 18 | 87 | 6.10% | 8,638,276 | 5.62% | 27.05% | 3.96% | 41 | 2.50% | 22 | -4.35% |
| 30 Sep, 18 | 82 | 2.50% | 8,178,397 | 4.50% | 26.12% | 3.92% | 40 | -31.03% | 23 | 283.33% |
| 30 Jun, 18 | 80 | 45.45% | 7,826,543 | 99.37% | 25.83% | 14.44% | 58 | 70.59% | 6 | -25.00% |
| 31 Mar, 18 | 55 | 12.24% | 3,925,584 | 22.42% | 13.37% | 11.21% | 34 | - | 8 | 33.33% |
| 31 Dec, 17 | 49 | 36.11% | 3,206,663 | 29.19% | 10.93% | 14.11% | 34 | 126.67% | 6 | - |
| 30 Sep, 17 | 36 | 2.86% | 2,482,137 | 28.06% | 8.80% | 18.30% | 15 | 36.36% | 6 | -57.14% |
| 30 Jun, 17 | 35 | -7.89% | 1,938,266 | -21.01% | 6.93% | 7.49% | 11 | -47.62% | 14 | 55.56% |
| 31 Mar, 17 | 38 | -7.32% | 2,453,743 | 53.86% | 9.62% | 24.60% | 21 | 16.67% | 9 | - |
| 31 Dec, 16 | 41 | 7.89% | 1,594,828 | 1.62% | 6.25% | 16.44% | 18 | -5.26% | 9 | 12.50% |
| 30 Sep, 16 | 38 | - | 1,569,433 | -11.50% | 6.17% | 12.67% | 19 | 11.76% | 8 | 33.33% |
| 30 Jun, 16 | 38 | 2.70% | 1,773,298 | 25.58% | 6.98% | 20.83% | 17 | 30.77% | 6 | -14.29% |
| 31 Mar, 16 | 37 | -15.91% | 1,412,125 | 2.64% | 5.79% | 18.21% | 13 | -48.00% | 7 | 16.67% |
| 31 Dec, 15 | 44 | 18.92% | 1,375,745 | 1.86% | 5.64% | 19.37% | 25 | 78.57% | 6 | -33.33% |
| 30 Sep, 15 | 37 | 8.82% | 1,350,665 | 8.73% | 5.39% | 21.45% | 14 | -26.32% | 9 | 125.00% |
| 30 Jun, 15 | 34 | 17.24% | 1,242,189 | 30.15% | 5.02% | 32.77% | 19 | -24.00% | 4 | - |
| 31 Mar, 15 | 29 | 222.22% | 954,417 | 142.09% | 3.91% | 52.07% | 25 | 177.78% | - | - |
| 31 Dec, 14 | 9 | - | 394,240 | - | 2.74% | - | 9 | - | - | - |
Cytosorbents Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
Cytosorbents Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 5 | - | - |
| Q2 2024 | 12 | - | - |
| Q1 2024 | 4 | - | - |
| Q4 2023 | 16 | - | - |
| Q3 2023 | 17 | 4 | 425.00% |
| Q2 2023 | 8 | 2 | 400.00% |
| Q1 2023 | 2 | 2 | 100.00% |
| Q4 2022 | 3 | - | - |
| Q3 2022 | 22 | - | - |
| Q2 2022 | 19 | - | - |
| Q1 2022 | 1 | - | - |
| Q4 2021 | 6 | 2 | 300.00% |
| Q3 2021 | 1 | 2 | 50.00% |
| Q2 2021 | 12 | - | - |
| Q4 2020 | 2 | 3 | 66.67% |
| Q3 2020 | 3 | 1 | 300.00% |
| Q2 2020 | 5 | 4 | 125.00% |
| Q1 2020 | 12 | 3 | 400.00% |
| Q4 2019 | 3 | - | - |
| Q3 2019 | 17 | 3 | 566.67% |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cytosorbents's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 16 | - | - |
| Q3 2023 | 3 | - | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 3 | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 18 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 5 | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | - | - |
| Q4 2020 | - | 1 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | 1 | - |
| Q1 2020 | - | 1 | - |
| Q4 2019 | 3 | - | - |
| Q3 2019 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cytosorbents's stocks.
Cytosorbents Peer Ownership
| Ticker | Company |
|---|---|
| FNA | Paragon 28, Inc. |
| APYX | Apyx Medical Corporation |
| OFIX | Orthofix Medical Inc. |
| LUNG | Pulmonx Corporation |
| CLPT | ClearPoint Neuro, Inc. |
| TELA | TELA Bio, Inc. |
| NPCE | NeuroPace, Inc. |
| SRDX | Surmodics, Inc. |
| LIVN | LivaNova PLC |
| KIDS | OrthoPediatrics Corp. |
| OSA | ProSomnus, Inc. Common Stock |
| AORT | Artivion, Inc. |
| INGN | Inogen, Inc. |
| CVRX | CVRx, Inc. |
CTSO Ownership FAQ
Who Owns Cytosorbents?
Cytosorbents is owned by institutional shareholders (19.17%), insiders (3.84%), and public (76.99%). The largest institutional shareholder of Cytosorbents is AVENIR CORP (5.47% of total shares) and the top mutual fund owner is SPARROW FUNDS (3.89% of total shares).
Who are the major institutional shareholders of Cytosorbents?
Cytosorbents's major institutional shareholders are AVENIR CORP, SKYLANDS CAPITAL, LLC, GRANAHAN INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, and NEUBERGER BERMAN GROUP LLC. The top five shareholders own together 22.04% of the company's share outstanding.
How many Cytosorbents shareholders are there?
As of Jun 2024, there are 32 institutional shareholders of Cytosorbents.
What percentage of Cytosorbents is owned by AVENIR CORP?
AVENIR CORP owns 2.97M shares of Cytosorbents, representing 5.47% of the company's total shares outstanding, valued at $2.09M (as of Jun 2024).
What percentage of Cytosorbents is owned by SKYLANDS CAPITAL, LLC?
As of Jun 2024, SKYLANDS CAPITAL, LLC holds 2.84M shares of Cytosorbents (CTSO), compromising 5.24% of the company, valued at $2M.
What percentage of Cytosorbents is owned by GRANAHAN INVESTMENT MANAGEMENT, LLC?
GRANAHAN INVESTMENT MANAGEMENT, LLC is the third largest holder of Cytosorbents. The company owns 2.66M of the company's shares outstanding (worth $1.87M).